BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30887204)

  • 1. Annual mammography at age 45-49 years and biennial mammography at age 50-69 years: comparing performance measures in an organised screening setting.
    Bucchi L; Ravaioli A; Baldacchini F; Giuliani O; Mancini S; Vattiato R; Falcini F; Giorgi Rossi P; Campari C; Canuti D; Di Felice E; Sassoli de Bianchi P; Ferretti S; Bertozzi N;
    Eur Radiol; 2019 Oct; 29(10):5517-5527. PubMed ID: 30887204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nation-wide data on screening performance during the transition to digital mammography: observations in 6 million screens.
    van Luijt PA; Fracheboud J; Heijnsdijk EA; den Heeten GJ; de Koning HJ;
    Eur J Cancer; 2013 Nov; 49(16):3517-25. PubMed ID: 23871248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.
    Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA;
    JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast Cancer Screening With Mammography Plus Ultrasonography or Magnetic Resonance Imaging in Women 50 Years or Younger at Diagnosis and Treated With Breast Conservation Therapy.
    Cho N; Han W; Han BK; Bae MS; Ko ES; Nam SJ; Chae EY; Lee JW; Kim SH; Kang BJ; Song BJ; Kim EK; Moon HJ; Kim SI; Kim SM; Kang E; Choi Y; Kim HH; Moon WK
    JAMA Oncol; 2017 Nov; 3(11):1495-1502. PubMed ID: 28655029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study.
    Ciatto S; Houssami N; Bernardi D; Caumo F; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Montemezzi S; Macaskill P
    Lancet Oncol; 2013 Jun; 14(7):583-9. PubMed ID: 23623721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study.
    Bernardi D; Macaskill P; Pellegrini M; Valentini M; Fantò C; Ostillio L; Tuttobene P; Luparia A; Houssami N
    Lancet Oncol; 2016 Aug; 17(8):1105-1113. PubMed ID: 27345635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening outcome and surgical treatment during and after the transition from screen-film to digital screening mammography in the south of The Netherlands.
    Weber RJ; Nederend J; Voogd AC; Strobbe LJ; Duijm LE
    Int J Cancer; 2015 Jul; 137(1):135-43. PubMed ID: 25418512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study.
    Hubbard RA; Kerlikowske K; Flowers CI; Yankaskas BC; Zhu W; Miglioretti DL
    Ann Intern Med; 2011 Oct; 155(8):481-92. PubMed ID: 22007042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of screening mammography in the United States and the United kingdom.
    Smith-Bindman R; Chu PW; Miglioretti DL; Sickles EA; Blanks R; Ballard-Barbash R; Bobo JK; Lee NC; Wallis MG; Patnick J; Kerlikowske K
    JAMA; 2003 Oct; 290(16):2129-37. PubMed ID: 14570948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency and diagnostic outcome of bilateral recall at screening mammography.
    Lameijer JRC; Nederend J; Voogd AC; Tjan-Heijnen VCG; Duijm LEM
    Int J Cancer; 2021 Jan; 148(1):48-56. PubMed ID: 32621785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating wait times from screening to breast cancer diagnosis among women undergoing organised assessment vs usual care.
    Chiarelli AM; Muradali D; Blackmore KM; Smith CR; Mirea L; Majpruz V; O'Malley FP; Quan ML; Holloway CM
    Br J Cancer; 2017 May; 116(10):1254-1263. PubMed ID: 28359079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast Biopsy Intensity and Findings Following Breast Cancer Screening in Women With and Without a Personal History of Breast Cancer.
    Buist DSM; Abraham L; Lee CI; Lee JM; Lehman C; O'Meara ES; Stout NK; Henderson LM; Hill D; Wernli KJ; Haas JS; Tosteson ANA; Kerlikowske K; Onega T;
    JAMA Intern Med; 2018 Apr; 178(4):458-468. PubMed ID: 29435556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tailored Breast Screening Trial (TBST)].
    Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
    Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection Rate, Recall Rate, and Positive Predictive Value of Digital Compared to Screen-Film Mammography in the Quebec Population-Based Breast Cancer Screening Program.
    Théberge I; Vandal N; Langlois A; Pelletier É; Brisson J
    Can Assoc Radiol J; 2016 Nov; 67(4):330-338. PubMed ID: 27451910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of Screening Ultrasonography as an Adjunct to Screening Mammography in Women Across the Spectrum of Breast Cancer Risk.
    Lee JM; Arao RF; Sprague BL; Kerlikowske K; Lehman CD; Smith RA; Henderson LM; Rauscher GH; Miglioretti DL
    JAMA Intern Med; 2019 May; 179(5):658-667. PubMed ID: 30882843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance measures among non-immigrants and immigrants attending BreastScreen Norway: a population-based screening programme.
    Bhargava S; Akslen LA; Bukholm IRK; Hofvind S
    Eur Radiol; 2019 Sep; 29(9):4833-4842. PubMed ID: 30762109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cumulative 6-Year Risk of Screen-Detected Ductal Carcinoma In Situ by Screening Frequency.
    Sprague BL; Chen S; Miglioretti DL; Gard CC; Tice JA; Hubbard RA; Aiello Bowles EJ; Kaufman PA; Kerlikowske K
    JAMA Netw Open; 2023 Feb; 6(2):e230166. PubMed ID: 36808238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long term breast cancer screening in Nijmegen, The Netherlands: the nine rounds from 1975-92.
    Otten JD; van Dijck JA; Peer PG; Straatman H; Verbeek AL; Mravunac M; Hendriks JH; Holland R
    J Epidemiol Community Health; 1996 Jun; 50(3):353-8. PubMed ID: 8935470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasound as the Primary Screening Test for Breast Cancer: Analysis From ACRIN 6666.
    Berg WA; Bandos AI; Mendelson EB; Lehrer D; Jong RA; Pisano ED
    J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26712110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing the performance of mammography screening in the USA and the UK.
    Smith-Bindman R; Ballard-Barbash R; Miglioretti DL; Patnick J; Kerlikowske K
    J Med Screen; 2005; 12(1):50-4. PubMed ID: 15814020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.